Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

Interaction between endogenous bacterial flora and latent HIV infection.

Victoriano AF, Imai K, Okamoto T.

Clin Vaccine Immunol. 2013 Jun;20(6):773-9. doi: 10.1128/CVI.00766-12. Epub 2013 Apr 24. Review.

2.

MicroRNAs in HIV-1 infection: an integration of viral and cellular interaction at the genomic level.

Tan Gana NH, Onuki T, Victoriano AF, Okamoto T.

Front Microbiol. 2012 Aug 24;3:306. doi: 10.3389/fmicb.2012.00306. eCollection 2012.

3.
4.

Evaluation of online miRNA resources for biomedical applications.

Tan Gana NH, Victoriano AF, Okamoto T.

Genes Cells. 2012 Jan;17(1):11-27. doi: 10.1111/j.1365-2443.2011.01564.x. Epub 2011 Nov 13. Review.

5.

Transcriptional control of HIV replication by multiple modulators and their implication for a novel antiviral therapy.

Victoriano AF, Okamoto T.

AIDS Res Hum Retroviruses. 2012 Feb;28(2):125-38. doi: 10.1089/AID.2011.0263. Review.

PMID:
22077140
6.

Functional characterization of human cyclin T1 N-terminal region for human immunodeficiency virus-1 Tat transcriptional activation.

Asamitsu K, Hibi Y, Imai K, Victoriano AF, Kurimoto E, Kato K, Okamoto T.

J Mol Biol. 2011 Jul 29;410(5):887-95. doi: 10.1016/j.jmb.2011.04.061.

PMID:
21763494
7.

Novel histone deacetylase inhibitor NCH-51 activates latent HIV-1 gene expression.

Victoriano AF, Imai K, Togami H, Ueno T, Asamitsu K, Suzuki T, Miyata N, Ochiai K, Okamoto T.

FEBS Lett. 2011 Apr 6;585(7):1103-11. doi: 10.1016/j.febslet.2011.03.017. Epub 2011 Mar 12.

8.

Cyclin T1 stabilizes expression levels of HIV-1 Tat in cells.

Imai K, Asamitsu K, Victoriano AF, Cueno ME, Fujinaga K, Okamoto T.

FEBS J. 2009 Dec;276(23):7124-33. doi: 10.1111/j.1742-4658.2009.07424.x.

9.

Leptospirosis in the Asia Pacific region.

Victoriano AF, Smythe LD, Gloriani-Barzaga N, Cavinta LL, Kasai T, Limpakarnjanarat K, Ong BL, Gongal G, Hall J, Coulombe CA, Yanagihara Y, Yoshida S, Adler B.

BMC Infect Dis. 2009 Sep 4;9:147. doi: 10.1186/1471-2334-9-147. Review.

10.

Inhibition of human immunodeficiency virus type 1 replication by blocking IkappaB kinase with noraristeromycin.

Asamitsu K, Yamaguchi T, Nakata K, Hibi Y, Victoriano AF, Imai K, Onozaki K, Kitade Y, Okamoto T.

J Biochem. 2008 Nov;144(5):581-9. doi: 10.1093/jb/mvn104. Epub 2008 Aug 19.

PMID:
18713798
11.

A single-nucleotide synonymous mutation in the gag gene controlling human immunodeficiency virus type 1 virion production.

Hamano T, Matsuo K, Hibi Y, Victoriano AF, Takahashi N, Mabuchi Y, Soji T, Irie S, Sawanpanyalert P, Yanai H, Hara T, Yamazaki S, Yamamoto N, Okamoto T.

J Virol. 2007 Feb;81(3):1528-33. Epub 2006 Nov 22.

12.

Inhibition of human immunodeficiency virus type 1 replication in latently infected cells by a novel IkappaB kinase inhibitor.

Victoriano AF, Asamitsu K, Hibi Y, Imai K, Barzaga NG, Okamoto T.

Antimicrob Agents Chemother. 2006 Feb;50(2):547-55.

13.

Estrogen stimulates transcription of human immunodeficiency virus type 1 (HIV-1).

Katagiri D, Hayashi H, Victoriano AF, Okamoto T, Onozaki K.

Int Immunopharmacol. 2006 Feb;6(2):170-81. Epub 2005 Sep 2.

PMID:
16399621

Supplemental Content

Loading ...
Support Center